Authors

  • Negmatova Gulzoda Shuhratovna
    Samarkand State Medical Institute, Samarkand, Republic Of Uzbekistan

DOI:

https://doi.org/10.37547/TAJMSPR/Volume02Issue07-04

Keywords:

autoimmune polyglandular syndrome type 2, type 1 diabetes mellitus

Abstract

The article considers a clinical case of a young patient with autoimmune polyglandular
syndrome type 2, represented by type 1 diabetes mellitus, thyroid dysfunction and
primary adrenal cortex insufficiency.

References

Betterle C., Zanchetta R. Update on autoimmune polyendocrine syndromes (APS).

Clinical Immunology and Allergology. Acta Bio Medica 2003; 74: 1: 9-33.

Kahaly G.J. Polyglandular autoimmune syndromes. Eur J Endocrinol 2009; 161: 1: 11-

doi: 10.1530/eje-09-0044.

Endocrinology. National leadership. Edited By I. I. Dedov, G. A. Melnichenko. M:

GEOTAR-Media, 2008.

Yu. I. Klyuchagina1, Z. A. Sokolova2, M. A. Baryshnikov2. The role of the PD-1 receptor

and its PDL1 and PDL2 ligands in tumor immunotherapy. Oncopediatrics. 2017, 4 (1) 49-

pages.

L. Tsarev , A.V. Melerzanov, Review of approaches to immunotherapy in Oncology.

Journal of Research and practice in medicine 2017, vol. 4, no. 3, pp. 51-65 REVIEW DOI: